LDL受容体の翻訳後の処理と,家族性高コレステロール血症におけるその遺伝的破壊
Cell
|October 1, 1982
まとめ
研究者は,培養ヒト線維芽細胞における低密度リポタンパク質 (LDL) 受容体合成と処理を研究した. 彼らは,家族性高コレステロール血症における新しい処理ステップと障害を特定し,LDL受容体遺伝子変異の洞察を明らかにしました.
科学分野:
- 分子生物学は分子生物学である.
- バイオケミストリー バイオケミストリー
- 遺伝学 遺伝学とは
背景:
- 低密度脂質タンパク質 (LDL) 受容体は,細胞のコレステロール吸収を媒介する.
- LDL受容体の合成と処理を理解することは,脂質代謝障害において極めて重要です.
研究 の 目的:
- LDL受容体の合成と翻訳後の改変を調査する.
- 家族性高コレステロール血症におけるLDL受容体の処理欠陥を調査する.
主な方法:
- 培養したヒト線維芽細胞を35S-メチオニンで化した.
- 免疫プレシピテーションは,LDL受容体に対するモノクローナル抗体を使用して行われました.
主要な成果:
- LDL受容体は120kd前駆体として合成され,新しい処理経路を通じて160kdの形に成熟します.
- ホモジゴス家族性高コレステロール血症の患者からの線維芽細胞は,受容体処理の障害を示した.
- 特定の変異により,異常な前駆体 (120kdおよび170kd) と成熟した受容体 (160kdおよび210kd) が生じた.
結論:
- LDL受容体の成熟には,新しい翻訳後の修正が関与している.
- 欠陥のあるLDL受容体の処理は,特定の家族性高コレステロール血症のフェノタイプの特徴です.
- LDL受容体遺伝子の変異は,明確な処理異常につながる可能性があります.
関連する概念動画
Receptor-mediated Endocytosis
105.3K
Overview
105.3K
Inflammation
46.1K
Overview
46.1K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Cholesterol: Significance and Regulation
1.9K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.9K
Pharmacogenomics: Identification of New Drug Targets
117
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
117
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K


